Transcriptic is a startup company that participated in Y Combinator's W15 batch, indicating its startup status. The company is primarily engaged in developing a robotic cloud lab platform, which integrates AI and IoT technologies to automate laboratory processes. This aligns with the core business of artificial intelligence. Additionally, Transcriptic is focused on life sciences, as it aims to transform drug discovery and synthetic biology research.
Tamarind Bio is a startup company (part of Y Combinator's W24 batch) that focuses on computational biology tools, which involves artificial intelligence. Their focus on structural biology, protein structure prediction, protein design, and molecular docking indicates a strong emphasis on life sciences.
BenchSci is a startup company that has developed ASCEND, a GenAI platform designed to accelerate drug discovery and complex research workflows across therapeutic areas. The company is primarily engaged in artificial intelligence as their core business, utilizing biology-specific multimodal AI to understand biomedical experiments. Additionally, BenchSci is focused on life sciences, specifically in the area of drug discovery and biomedical research.
Scanbase is a startup company with a team size of 6, participated in Y Combinator's W23 batch, and is primarily engaged in artificial intelligence, machine learning, and computer vision technologies. The company focuses on healthcare diagnostics, which falls under the life sciences category, providing AI-powered test results interpretation and digital health diagnostics solutions.
Serinus Biosciences is a startup company (part of Y Combinator batch S22) that primarily engages in artificial intelligence (utilizes a fully explainable AI platform) and focuses on life sciences (specifically cancer treatment and precision medicine).
eCellula is a startup company that offers best-in-class AI applications for advancements in life sciences, indicating that it is primarily engaged in artificial intelligence and focused on life sciences.
Duos is a startup company founded in 2020 that primarily engages in artificial intelligence through its AI-powered digital experiences and recommendation engine. The company focuses on life sciences by improving health outcomes and satisfaction for Medicare beneficiaries, addressing social determinants of health, and providing care navigation solutions.
Aspen Neuroscience is a startup company founded in 2018, primarily engaged in artificial intelligence as part of their core business, and focused on life sciences, specifically personalized cell therapies for Parkinson's disease.
InstaDeep is a startup company that develops AI-powered decision-making systems and has a focus on life sciences, as evidenced by their product DeepChain™ and their recent acquisition by BioNTech to enhance AI-driven biotechnology solutions.
Cancel
